LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.97
+0.09 (1.21%)
Aug 14, 2026, 4:00 PM EDT - Market closed
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $74.82 million as of August 14, 2026. Its market cap has increased by 386.43% in one year.
Market Cap
74.82M
Enterprise Value
24.33M
1-Year Change
386.43%
Ranking
Category
Stock Price
$7.97
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $74.82M, a decrease of -85.81%. That is a compound annual growth rate of -28.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 74.82M | 150.61% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 78.70M |
| NeurAxis | 78.02M |
| Eloxx Pharmaceuticals | 75.72M |
| Gossamer Bio | 75.38M |
| Telomir Pharmaceuticals | 74.96M |
| Atara Biotherapeutics | 72.89M |
| Elicio Therapeutics | 72.47M |
| Dogwood Therapeutics | 72.30M |